The immune system exists in harmony and also with the potential for dynamic control in healthy individuals. Our healthy body needs to sense the presence of microbes and react through both innate and adaptive immunity to eliminate infection. How our immune system senses the initiation, progression, and termination of the inflammatory process is critical for maintaining immune homeostasis. Thanks to the elegant experimental progress in using conditional knockout animal models, we have, over the past decade, gained a deep understanding of the contributions of thymusderived CD4
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Although there have been many advances in our understanding, it remains unclear how the adaptive immune system, including natural and induced Foxp3 1 Tregs, plays a central role in suppressing immune responses, sensing inflammation, and ensuring appropriately timed and localized immune responses, especially in humans. 1, 2 It is still actively debated whether Treg plasticity exists and/or how it is dynamically controlled both in healthy and inflammation states. On the one hand, it has been convincingly demonstrated that the Foxp3 gene locus is consistently demethylated and actively transcribed in natural Treg cells. [3] [4] [5] On the other hand, the Foxp3 protein is regulated at the posttranslational level by acetylation, phosphorylation, and ubiquitination, which detemine its DNA binding, protein stability, and degradation under inflammation. [6] [7] [8] [9] [10] Understanding functional plasticity and stability could provide new insights in promoting Treg-based clinical therapies for autoimmune disease, organ transplantation, and cancer.
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In this issue, we have assembled a series of up-to-date reviews on the functional plasticity of Tregs to address and discuss how Tregs may sense the initiation and progression of inflammation in different physiological microenvironments. In an inflammatory micro- 
